Benefits
Diclo Plus Injection provides fast and effective relief from acute pain and inflammation, making it a trusted pain relief injection in clinical practice. It is especially beneficial for post-operative pain, musculoskeletal pain, joint pain, arthritis, and acute back pain, where rapid action is required. Diclo Plus Injection helps reduce swelling, stiffness, and discomfort, improves patient mobility, and is widely used as a diclofenac-based injection for short-term pain management when oral medicines are not suitable, under medical supervision.
Usage Instructions
Diclo Plus Injection should be administered only by a qualified healthcare professional. It is usually given as an intramuscular (IM) injection for the short-term management of acute pain and inflammation. The dosage and duration of treatment depend on the patient’s condition, severity of pain, and medical history, and must be strictly followed as prescribed by the physician. Diclo Plus Injection is not recommended for self-administration or long-term use and should be used under medical supervision to ensure safety and effectiveness.
Indications
Diclo Plus Injection is indicated for the short-term management of acute pain and inflammation, particularly in situations where rapid pain relief is required and oral pain medications are not suitable or effective.
Contraindications
Diclo Plus Injection has the following side effects
Known hypersensitivity or allergy to diclofenac, NSAIDs, or any component of the formulation
History of bronchospasm, asthma, or allergic reactions triggered by non-steroidal anti-inflammatory drugs (NSAIDs)
Active gastrointestinal bleeding, peptic ulcer disease, or gastrointestinal perforation
Severe hepatic (liver) impairment
Severe renal (kidney) dysfunction or renal failure
Severe heart failure or established cardiovascular disease
Third trimester of pregnancy, unless strictly advised by a qualified physician
Diclo Plus Injection should always be administered under medical supervision, and careful risk–benefit assessment is recommended in high-risk patients.